Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 23756.0 | 48 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 24532.0 | 35 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 28913.0 | 48 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 34070.0 | 45 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 10022.0 | 45 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 9310.0 | 37 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 18188.0 | 71 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 20196.0 | 69 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 455.0 | 43 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 905.0 | 47 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 71.0 | 31 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 129.0 | 35 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 277.0 | 63 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 333.0 | 37 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 184.5 | 48 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 776.0 | 56 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 3755.5 | 42 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 3269.0 | 55 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 7873.0 | 37 | |
N2759 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 8058.0 | 51 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 479.0 | 50 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 490.0 | 60 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 3627.5 | 86 | |
N2586 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 4303.5 | 78 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-3 | 393.0 | 34 |